Hardy Alexander — SEC Form 4 filings

SEC reporting owner CIK 2001910. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-19 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)Chief Executive Officer, Director613

Form 4 filings — Hardy Alexander

FiledFormIssuerReported transactionsSource
2026-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 4,252 @ $56.05EDGAR
2026-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 2,941 @ $58.51 · Grant/award (A): 62,440 @ $0 · Grant/award (A): 89,200 (derivative) @ $0EDGAR
2025-12-024BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 375 @ $54.14 · Tax withholding (F): 16,570 @ $55.03EDGAR
2025-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 2,933 @ $69.44 · Grant/award (A): 44,360 @ $0 · Grant/award (A): 61,750 (derivative) @ $0EDGAR
2024-12-034BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 300 @ $56.01 · Tax withholding (F): 14,295 @ $66.03EDGAR
2024-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 32,780 @ $0 · Grant/award (A): 44,050 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2001910 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →